🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- G011FJXV4 (prev. G50752107 )
- Market Cap
- Micro Cap
- IPO
- 7/14/2021 · $10.00/unit
- Previous Symbol
- JATT (changed 3/20/2023)
- Previous Name
- JATT Acquisition Corp
Business: Zura Bio Limited is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab. ZB-168 is an anti IL7R α inhibitor that has the potential to impact diseases driven by IL7 and TSLP biological pathways. Torudokimab is a fully human, high affinity monoclonal antibody that neutralizes IL33 and is currently at the Phase 2 clinical development stage.
Company Contact
- CEO
- Robert Lisicki
- CFO
- Verender Badial
- Headquarters
- 1489 W. Warm Springs Road, Suite 110, Henderson, NV 89014
- Phone
- 702-852-9872
- Investor Relations
- Kim Davis · info@zurabio.com